Dr Cinzia Canipari

Dr Cinzia Canipari is a highly regarded Consultant Medical Oncologist who specialises in the diagnosis, treatment, and management of a diverse range of cancers. With a strong clinical focus on upper gastrointestinal (GI) and urological malignancies, she serves as a leading specialist in co-ordinating complex systemic therapies. Dr Canipari is dedicated to delivering personalised, evidence-based care, ensuring that each patient receives a tailored treatment plan designed to achieve the best possible clinical outcomes. Her reassuring and patient-centred approach helps individuals navigate their treatment journeys with confidence and clarity.

Throughout her career, Dr Canipari has developed extensive expertise in Systemic Anti-Cancer Therapy (SACT), including advanced chemotherapy and targeted therapies. Her clinical interests encompass the management of oesophago-gastric, pancreaticobiliary, and urological cancers, such as renal cell carcinoma and prostate cancer. Additionally, she has a keen interest in breast cancer treatments and innovative therapies for haematological malignancies. As a Governance and SACT Lead, she is actively involved in maintaining the highest standards of patient safety and clinical excellence, ensuring that the delivery of cancer therapies aligns with the latest medical advancements.

Dr Canipari completed her medical degree and specialist oncology training in Italy, conducting significant clinical research at the University of Pavia and the University of Genoa. Her academic contributions include extensive research into predictive biomarkers for kidney cancer and targeted therapies, for which she was awarded the prestigious Candido Costa Prize. Committed to continuous professional development and the advancement of oncology care, she is an active member of the Association of Cancer Physicians. Her dedication to clinical research and medical education ensures her patients benefit from cutting-edge, scientifically validated oncological care.